Human papillomavirus DNA vaccine - PowderMed

Drug Profile

Human papillomavirus DNA vaccine - PowderMed

Alternative Names: Genital warts DNA vaccine - PowderMed; HPV DNA vaccine - PowderMed

Latest Information Update: 04 Aug 2009

Price : $50

At a glance

  • Originator PowderMed
  • Class Cancer vaccines; DNA vaccines; Gene therapies; Papillomavirus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Human papillomavirus infections

Most Recent Events

  • 04 Aug 2009 No development reported - Preclinical for Human papillomavirus infections in United Kingdom (Intradermal)
  • 03 Jun 2004 Preclinical trials in Human papillomavirus infections in United Kingdom (Intradermal)
  • 03 Jun 2004 PowderMed, an independent company spun off from Chiron Vaccines is now developing the Human papillomavirus DNA vaccine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top